You are viewing the site in preview mode
Skip to main content
|
Variable
|
N
|
%
|
|---|
|
Ages, yrs, mean ± SD (IQR)
|
44.1 ± 13.8 (33–54)
|
–
|
|
≥ 45
|
29
|
48.3
|
|
≥ 55
|
14
|
23.3
|
|
Sex, male/female
|
18/42
|
30.0/70.0
|
|
BMI
|
23.1 ± 3.7
| |
|
NG
|
24
|
40.0
|
|
HD
|
8
|
13.3
|
|
Hypertension
|
5
|
8.3
|
|
Diabetes
|
3
|
5.0
|
|
Hyperthyroidism
|
5
|
8.3
|
|
Hypothyroidism
|
0
|
0
|
|
Tumor size (primary), mm
|
|
Mean ± SD (IQR)
|
21.7 ± 14.3 (10.75–22.25)
| |
|
> 40 mm
|
7
|
11.7
|
|
Multifocality (primary)
|
11
|
18.3
|
|
Bilaterality (primary)
|
8
|
13.3
|
|
TgAb positive (> 115U/mL)
|
8
|
13.3
|
|
TNM stage (primary)
|
|
Tx/T1/T2/T3/T4
|
8/11/6/16/19
|
13.3/18.3/10.0/26.7/31.7
|
|
Nx/N0/N1a/N1b
|
0/11/12/37
|
0/18.3/20.0/61.7
|
|
Mx/M0/M1
|
1/59/0
|
1.7/98.3/0
|
|
Surgical strategy
|
|
iCND/bCND
|
4/15
|
6.7/25.0
|
|
iCND + iLND
|
7
|
11.7
|
|
bCND + iLND
|
24
|
40.0
|
|
bCND + bLND
|
10
|
16.7
|
|
Harvested LNs
|
33.0 ± 20.8
| |
|
Metastatic LNs
|
8.5 ± 8.2
| |
|
The ratio of metastatic LNs %
|
29.5 ± 23.1
| |
|
RAI Administration
|
49
|
81.7
|
|
Central LNs recurrence
|
19
|
31.7
|
|
Lateral LNs recurrence
|
36
|
60.0
|
|
Central & lateral LNs recurrence
|
5
|
8.3
|
|
Diameters of recurrent LNs, mm, Mean ± SD (IQR)
|
18.7 ± 12.9 (10.75–22.00)
| |
|
Extranodal extension
|
20
|
33.3
|
- BMI Body Mass Index, HD Hashimoto's disease, NG nodular goiter, iCND ipsilateral central neck dissection, bCND bilateral central neck dissection, iLND ipsilateral lateral neck dissection, bLND bilateral lateral neck dissection, LN lymph node
